Results of a 1-year randomised double-blind placebo-controlled trial with methotrexate 25 mg/week in rheumatica

Authors
Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2026
This article has no abstract
Epistemonikos ID: 7e8f39122c8458be53676bbb06e0e46d18259da4
First added on: Oct 24, 2026